PATHFINDER CELL THERAPY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | -.--% |
Volumes
marketsDaily volume
500
Estimated daily volume
500
Record volume 1
4 507 415
Record volume 2
3 679 025
Record volume 3
1 752 829
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
667
Net sales ()
0
Number of employees
1
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
100 %
Free-Float capitalization (USD)
667
Highs and lows
3 years
0.00
0.03
5 years
0.000.03
10 years
0.000.05
Indicators
RSI 9 days
0.00
RSI 14 days
0.00
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 667 | ||
| -0.13% | +2.10% | +49.21% | +20.39% | 56.87B | ||
| -3.50% | -4.53% | +34.69% | -15.20% | 39.72B | ||
| -0.15% | -0.77% | -6.86% | +4.32% | 39.27B | ||
| +1.64% | +2.39% | -4.42% | +13.96% | 28.73B | ||
| -0.88% | -0.33% | +12.00% | +42.86% | 26.21B | ||
| +1.93% | +4.45% | -18.27% | -18.03% | 19.79B | ||
| -2.10% | +0.89% | +29.57% | +91.08% | 12.28B | ||
| +0.19% | +0.94% | +25.41% | +20.69% | 12.23B | ||
| -0.27% | -0.01% | -0.35% | -1.96% | 12.12B | ||
| -1.90% | +0.10% | -10.99% | +6.45% | 10.84B | ||
| -2.05% | +0.66% | -1.82% | -5.85% | 9.75B | ||
| -2.11% | -1.91% | +36.05% | +52.78% | 6.44B | ||
| -0.87% | -1.60% | +18.46% | -14.25% | 6.45B | ||
| +1.31% | +3.44% | +14.26% | +80.25% | 6.6B | ||
| -2.02% | +0.72% | +1.69% | -21.86% | 6.21B | ||
| Average | -0.68% | +0.85% | +11.91% | +17.04% | ||
| Weighted average by Cap. | -0.62% | +1.04% | +16.09% | +13.27% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -.--% | ||
| 2023 | -.--% | ||
| 2022 | -.--% | ||
| 2021 | -99.95% | ||
| 2020 | -9.52% | ||
| 2019 | +75.00% | ||
| 2018 | -43.13% | ||
| 2017 | +163.75% | ||
| 2016 | -74.19% | ||
| 2015 | +287.50% | ||
| 2014 | -94.29% | ||
| 2013 | -30.00% | ||
| 2012 | -60.00% | ||
| 2011 | -9.09% |
- Stock Market
- Equities
- PFND Stock
- Quotes Pathfinder Cell Therapy, Inc.
